Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 29, 2018 13:00 ET | Source: NeuroMetrix, Inc.

NeuroMetrix to Exhibit and Sponsor Symposium on the Early Diagnosis of Diabetic Peripheral Neuropathy at the Annual Meeting of NEURODIAB

WALTHAM, Mass., Aug. 29, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported that it will be both exhibiting and sponsoring a diabetic neuropathy symposium at the 28th Annual...
August 28, 2018 11:00 ET | Source: NeuroMetrix, Inc.

NeuroMetrix Reports Presentation of Clinical and Scientific Data on Quell Wearable Pain Relief Technology at PAINWeek 2018 National Conference

WALTHAM, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported that it will present three scientific posters at the upcoming PAINWeek 2018 National Pain Conference...
August 27, 2018 13:30 ET | Source: NeuroMetrix, Inc.

NeuroMetrix to Present at H.C.Wainwright & Co 20th Annual Global Investment Conference in New York City

WALTHAM, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) reported that the time previously announced for its presentation at the H.C.Wainwright 20th Annual Global...
August 23, 2018 13:30 ET | Source: NeuroMetrix, Inc.

NeuroMetrix Announces Participation at the 20th Annual Global Investment Conference in New York City September 4 - 6th, 2018

WALTHAM, Mass., Aug. 23, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today announced it will be a presenting company at the 20th Annual Global Investment Conference, sponsored by H.C....
August 21, 2018 14:30 ET | Source: NeuroMetrix, Inc.

NeuroMetrix Receives $3.8M Milestone Payment Under Its Collaboration with GSK Consumer Healthcare

WALTHAM, Mass., Aug. 21, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), today reported that it had achieved the second development milestone under its strategic collaboration with GSK...
July 19, 2018 07:00 ET | Source: NeuroMetrix, Inc.

NeuroMetrix Reports Q2 2018 Financial Results

WALTHAM, Mass., July 19, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported financial and business highlights for the quarter ended June 30, 2018. The Company develops and...
July 12, 2018 11:00 ET | Source: NeuroMetrix, Inc.

NeuroMetrix, Inc. Announces Date for 2018 Second Quarter Financial Results Conference Call

WALTHAM, Mass., July 12, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2018 second quarter financial results before the opening of the market...
July 05, 2018 13:00 ET | Source: NeuroMetrix, Inc.

NeuroMetrix Announces Issuance of New U.S. Patent for DPNCheck Point-of-Care Neuropathy Test Technology

WALTHAM, Mass., July 05, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,004,445. The patent covers...
June 28, 2018 12:27 ET | Source: NeuroMetrix, Inc.

NeuroMetrix PR Campaign Wins Gold at the Publicity Club of New England 2018 Bell Ringer Awards

WALTHAM, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) in conjunction with its public relations firm, InkHouse, received two prestigious awards at the 50th annual Bell...
June 26, 2018 11:00 ET | Source: NeuroMetrix, Inc.

NeuroMetrix Reports Publication of New Clinical Studies on DPNCheck

WALTHAM, Mass., June 26, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported publication of three new clinical studies on DPNCheck®, a point-of-care device that provides...